179 related articles for article (PubMed ID: 18268090)
1. Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
Polhemus ME; Remich S; Ogutu B; Waitumbi J; Lievens M; Ballou WR; Heppner DG
Antimicrob Agents Chemother; 2008 Apr; 52(4):1493-5. PubMed ID: 18268090
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone and proguanil hydrochloride for treatment of malaria.
Kremsner PG; Looareesuwan S; Chulay JD
J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628
[TBL] [Abstract][Full Text] [Related]
6. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
[TBL] [Abstract][Full Text] [Related]
8. NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
Teirlinck AC; Roestenberg M; van de Vegte-Bolmer M; Scholzen A; Heinrichs MJ; Siebelink-Stoter R; Graumans W; van Gemert GJ; Teelen K; Vos MW; Nganou-Makamdop K; Borrmann S; Rozier YP; Erkens MA; Luty AJ; Hermsen CC; Sim BK; van Lieshout L; Hoffman SL; Visser LG; Sauerwein RW
J Infect Dis; 2013 Feb; 207(4):656-60. PubMed ID: 23186785
[TBL] [Abstract][Full Text] [Related]
9. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
10. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
[TBL] [Abstract][Full Text] [Related]
11. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
Boggild AK; Parise ME; Lewis LS; Kain KC
Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Chenet SM; Oyarce A; Fernandez J; Tapia-Limonchi R; Weitzel T; Tejedo JR; Udhayakumar V; Jercic MI; Lucchi NW
Am J Trop Med Hyg; 2021 Mar; 104(5):1811-1813. PubMed ID: 33782210
[TBL] [Abstract][Full Text] [Related]
13. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
14. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
[No Abstract] [Full Text] [Related]
15. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
Durand R; Prendki V; Cailhol J; Hubert V; Ralaimazava P; Massias L; Bouchaud O; Le Bras J
Emerg Infect Dis; 2008 Feb; 14(2):320-2. PubMed ID: 18258131
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR
Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
18. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
20. Atovaquone/proguanil for plasmodium falciparum malaria.
Sehdev PS
Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
